170 related articles for article (PubMed ID: 12477476)
1. The prognostic significance of gastric juice CA 19-9 and CEA levels in gastric carcinoma patients.
Duraker N; Naci Celik A; Gençler N
Eur J Surg Oncol; 2002 Dec; 28(8):844-9. PubMed ID: 12477476
[TBL] [Abstract][Full Text] [Related]
2. The role of serum and gastric juice levels of carcinoembryonic antigen, CA19.9 and CA72.4 in patients with gastric cancer.
Tocchi A; Costa G; Lepre L; Liotta G; Mazzoni G; Cianetti A; Vannini P
J Cancer Res Clin Oncol; 1998; 124(8):450-5. PubMed ID: 9750022
[TBL] [Abstract][Full Text] [Related]
3. An endogastric capsule for measuring tumor markers in gastric juice: an evaluation of the safety and efficacy of a new diagnostic tool.
Muretto P; Graziano F; Staccioli MP; Barbanti I; Bartolucci A; Paolini G; Giordano D; Testa E; De Gaetano A
Ann Oncol; 2003 Jan; 14(1):105-9. PubMed ID: 12488301
[TBL] [Abstract][Full Text] [Related]
4. The prognostic significance of preoperative serum CA 19-9 in patients with resectable gastric carcinoma: comparison with CEA.
Duraker N; Celik AN
J Surg Oncol; 2001 Apr; 76(4):266-71. PubMed ID: 11320518
[TBL] [Abstract][Full Text] [Related]
5. Clinical significance and prognostic value of CA72-4 compared with CEA and CA19-9 in patients with gastric cancer.
Ychou M; Duffour J; Kramar A; Gourgou S; Grenier J
Dis Markers; 2000; 16(3-4):105-10. PubMed ID: 11381189
[TBL] [Abstract][Full Text] [Related]
6. Combined detection of CEA, CA 19-9, CA 242 and CA 50 in the diagnosis and prognosis of resectable gastric cancer.
Tian SB; Yu JC; Kang WM; Ma ZQ; Ye X; Cao ZJ; Yan C
Asian Pac J Cancer Prev; 2014; 15(15):6295-300. PubMed ID: 25124614
[TBL] [Abstract][Full Text] [Related]
7. Clinical importance of preoperative carcinoembryonic antigen and carbohydrate antigen 19-9 levels in gastric cancer.
Ishigami S; Natsugoe S; Hokita S; Che X; Tokuda K; Nakajo A; Iwashige H; Tokushige M; Watanabe T; Takao S; Aikou T
J Clin Gastroenterol; 2001 Jan; 32(1):41-4. PubMed ID: 11154168
[TBL] [Abstract][Full Text] [Related]
8. Levels of carcinoembryonic antigen and CA 19-9 in the sera and peritoneal washing of patients undergoing surgical treatment for gastric carcinoma.
Crepaldi-Filho R; Palma RT; Giusti MF; Bueno Mde A; Silva PS; Waisberg J
Arq Gastroenterol; 2008; 45(3):219-24. PubMed ID: 18852950
[TBL] [Abstract][Full Text] [Related]
9. Prognostic significance of CEA, CA 19-9 and CA 72-4 preoperative serum levels in gastric carcinoma.
Marrelli D; Roviello F; De Stefano A; Farnetani M; Garosi L; Messano A; Pinto E
Oncology; 1999 Jul; 57(1):55-62. PubMed ID: 10394126
[TBL] [Abstract][Full Text] [Related]
10. Prognostic value of preoperative serum levels of CEA, CA 19-9 and CA 72-4 in gastric carcinoma.
Reiter W; Stieber P; Reuter C; Nagel D; Cramer C; Pahl H; Fateh-Moghadam A
Anticancer Res; 1997; 17(4B):2903-6. PubMed ID: 9329559
[TBL] [Abstract][Full Text] [Related]
11. Prognostic Value of Preoperative Serum Levels of Five Tumor Markers (Carcinoembryonic Antigen, CA19-9, Alpha-fetoprotein, CA72-4, and CA125) in Gastric Cancer.
Kim JH; Jun KH; Jung H; Park IS; Chin HM
Hepatogastroenterology; 2014 May; 61(131):863-9. PubMed ID: 26176088
[TBL] [Abstract][Full Text] [Related]
12. CEA and CA 19.9 in gastric juice and serum: an aid in the diagnosis of gastric carcinoma?
Harrison JD; Stanley J; Morris DL
Eur J Surg Oncol; 1989 Jun; 15(3):253-7. PubMed ID: 2737312
[TBL] [Abstract][Full Text] [Related]
13. A prognostic value of CA 19-9 but not of CEA in patients with gastric cancer.
Victorzon M; Haglund C; Lundin J; Roberts PJ
Eur J Surg Oncol; 1995 Aug; 21(4):379-84. PubMed ID: 7664902
[TBL] [Abstract][Full Text] [Related]
14. The usefulness of CEA and/or CA19-9 in monitoring for recurrence in gastric cancer patients: a prospective clinical study.
Takahashi Y; Takeuchi T; Sakamoto J; Touge T; Mai M; Ohkura H; Kodaira S; Okajima K; Nakazato H;
Gastric Cancer; 2003; 6(3):142-5. PubMed ID: 14520526
[TBL] [Abstract][Full Text] [Related]
15. Carbohydrate antigen 19-9 is a useful prognostic marker in esophagogastric junction adenocarcinoma.
Tokunaga R; Imamura Y; Nakamura K; Uchihara T; Ishimoto T; Nakagawa S; Iwatsuki M; Baba Y; Sakamoto Y; Miyamoto Y; Yoshida N; Oyama S; Shono T; Naoe H; Saeki H; Oki E; Watanabe M; Sasaki Y; Maehara Y; Baba H
Cancer Med; 2015 Nov; 4(11):1659-66. PubMed ID: 26310928
[TBL] [Abstract][Full Text] [Related]
16. Carcinoembryogenic antigen and lysosomal enzymes in gastric juice as an aid in the diagnosis of gastric cancer.
Graffner H; Hultberg B
J Surg Oncol; 1983 Nov; 24(3):233-5. PubMed ID: 6226830
[TBL] [Abstract][Full Text] [Related]
17. Tumor markers for diagnosis, monitoring of recurrence and prognosis in patients with upper gastrointestinal tract cancer.
Jing JX; Wang Y; Xu XQ; Sun T; Tian BG; Du LL; Zhao XW; Han CZ
Asian Pac J Cancer Prev; 2014; 15(23):10267-72. PubMed ID: 25556459
[TBL] [Abstract][Full Text] [Related]
18. Serum carcinoembryonic antigen as a prognostic factor in resectable gastric cancer.
Tachibana M; Takemoto Y; Nakashima Y; Kinugasa S; Kotoh T; Dhar DK; Kohno H; Nagasue N
J Am Coll Surg; 1998 Jul; 187(1):64-8. PubMed ID: 9660027
[TBL] [Abstract][Full Text] [Related]
19. Colorectal carcinoma liver metastases: clinical significance of preoperative measurement of serum carcinoembryonic antigen and carbohydrate antigen 19-9 levels.
Ishizuka D; Shirai Y; Sakai Y; Hatakeyama K
Int J Colorectal Dis; 2001 Feb; 16(1):32-7. PubMed ID: 11317695
[TBL] [Abstract][Full Text] [Related]
20. Preoperative hCGbeta and CA 72-4 are prognostic factors in gastric cancer.
Louhimo J; Kokkola A; Alfthan H; Stenman UH; Haglund C
Int J Cancer; 2004 Oct; 111(6):929-33. PubMed ID: 15300805
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
